Physician profile
Michael W Lusko
NPI 1811953524
$4,748.86
in general payments reported to CMS, 2019-2025
26 companies · $561 in 2025
The $561 reported for 2025 was more than what 93% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,132 · 2020: $533 · 2021: $595 · 2022: $943 · 2023: $470 · 2024: $515 · 2025: $561.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,546.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,545.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,181.11 | 2019-2025 | Collagenase Santyl, Oasis, Grafix |
| Integra Lifesciences Corporation | $900.50 | 2019-2022 | |
| Abbvie INC. | $492.67 | 2021-2025 | |
| Kerecis Limited | $470.47 | 2019-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Surgiclose |
| Organogenesis INC. | $393.72 | 2019-2023 | Puraply |
| Abiomed | $137.68 | 2019-2025 | |
| Paratek Pharmaceuticals, INC. | $137.63 | 2022-2025 | Nuzyra |
| Progenacare Global, LLC | $132.79 | 2023-2024 | |
| Genentech USA, INC. | $122.09 | 2021 | |
| Aroa Biosurgery Incorporated | $113.00 | 2023-2025 | |
| Tei Medical INC. | $109.97 | 2019 | |
| Portola Pharmaceuticals, LLC | $100.00 | 2019 | |
| Pfizer INC. | $82.72 | 2024 | |
| Reapplix INC. | $59.39 | 2025 | 3c Patch Kit - Box |
| Mimedx Group, INC. | $51.74 | 2024-2025 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $38.26 | 2025 | Activ.A.C., Promogran Prisma, 3m Coban |
| Next Science LLC | $37.57 | 2023 | Xperience, Blastx, Surgx |
| Hydrofera LLC | $31.13 | 2023 | Hydrofera Blue |
| Bridgebio Pharma, INC. | $30.49 | 2025 | Attruby |
| Convatec INC. | $22.28 | 2022 | |
| Urgo Medical North America, LLC | $21.32 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Kci USA, INC. | $18.86 | 2022 | |
| Bsn Medical INC | $17.74 | 2022 | |
| Misonix INC | $17.14 | 2021 | |
| Allergan, INC. | $14.78 | 2019 | |
| Biotissue Holdings INC. | $13.81 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lusko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.